FI956074A0 - Asetyylikolinesteraasin inhibiittoreina toimivia 1-asemasta substituoituja isatiini- ja oksindolijohdannaisia - Google Patents
Asetyylikolinesteraasin inhibiittoreina toimivia 1-asemasta substituoituja isatiini- ja oksindolijohdannaisiaInfo
- Publication number
- FI956074A0 FI956074A0 FI956074A FI956074A FI956074A0 FI 956074 A0 FI956074 A0 FI 956074A0 FI 956074 A FI956074 A FI 956074A FI 956074 A FI956074 A FI 956074A FI 956074 A0 FI956074 A0 FI 956074A0
- Authority
- FI
- Finland
- Prior art keywords
- oxidol
- derivatives
- acetylcholinesterase inhibitors
- substituted isatin
- isatin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/38—Oxygen atoms in positions 2 and 3, e.g. isatin
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE19939302080A SE9302080D0 (sv) | 1993-06-16 | 1993-06-16 | New compounds |
PCT/SE1994/000448 WO1994029272A1 (fr) | 1993-06-16 | 1994-05-13 | Derives de l'isatine a substitution 1 et de l'oxindole utiles comme inhibiteurs de l'acetylcholinesterase |
Publications (2)
Publication Number | Publication Date |
---|---|
FI956074A FI956074A (fi) | 1995-12-18 |
FI956074A0 true FI956074A0 (fi) | 1995-12-18 |
Family
ID=20390305
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI956074A FI956074A0 (fi) | 1993-06-16 | 1995-12-18 | Asetyylikolinesteraasin inhibiittoreina toimivia 1-asemasta substituoituja isatiini- ja oksindolijohdannaisia |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0703901A1 (fr) |
JP (1) | JPH08511515A (fr) |
AU (1) | AU7010894A (fr) |
CA (1) | CA2164119A1 (fr) |
FI (1) | FI956074A0 (fr) |
IS (1) | IS4167A (fr) |
NO (1) | NO955074L (fr) |
SE (1) | SE9302080D0 (fr) |
WO (1) | WO1994029272A1 (fr) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9103752D0 (sv) * | 1991-12-18 | 1991-12-18 | Astra Ab | New compounds |
ATE249828T1 (de) | 1998-03-06 | 2003-10-15 | Astrazeneca Ab | Verwendung von isatin- und oxindolderivaten zur herstellung von arzeneimittel für die behandlung von mykobakteriellen erkrankungen |
US6218383B1 (en) | 1998-08-07 | 2001-04-17 | Targacept, Inc. | Pharmaceutical compositions for the prevention and treatment of central nervous system disorders |
CN1572299A (zh) | 1998-09-30 | 2005-02-02 | 武田药品工业株式会社 | 改善膀胱排泄能力的药物 |
US6417214B1 (en) | 1999-05-04 | 2002-07-09 | Wyeth | 3,3-substituted indoline derivatives |
US6306851B1 (en) | 1999-05-04 | 2001-10-23 | American Home Products Corporation | Cyclocarbamate and cyclic amide derivatives |
US6369056B1 (en) | 1999-05-04 | 2002-04-09 | American Home Products Corporation | Cyclic urea and cyclic amide derivatives |
US6423699B1 (en) | 1999-05-04 | 2002-07-23 | American Home Products Corporation | Combination therapies using benzimidazolones |
US6498154B1 (en) | 1999-05-04 | 2002-12-24 | Wyeth | Cyclic regimens using quinazolinone and benzoxazine derivatives |
US6339098B1 (en) | 1999-05-04 | 2002-01-15 | American Home Products Corporation | 2,1-benzisothiazoline 2,2-dioxides |
US6399593B1 (en) | 1999-05-04 | 2002-06-04 | Wyeth | Cyclic regimens using cyclic urea and cyclic amide derivatives |
US6319912B1 (en) | 1999-05-04 | 2001-11-20 | American Home Products Corporation | Cyclic regimens using 2,1-benzisothiazoline 2,2-dioxides |
US6509334B1 (en) | 1999-05-04 | 2003-01-21 | American Home Products Corporation | Cyclocarbamate derivatives as progesterone receptor modulators |
US6380178B1 (en) | 1999-05-04 | 2002-04-30 | American Home Products Corporation | Cyclic regimens using cyclocarbamate and cyclic amide derivatives |
US6380235B1 (en) | 1999-05-04 | 2002-04-30 | American Home Products Corporation | Benzimidazolones and analogues |
US6355648B1 (en) | 1999-05-04 | 2002-03-12 | American Home Products Corporation | Thio-oxindole derivatives |
US6358948B1 (en) | 1999-05-04 | 2002-03-19 | American Home Products Corporation | Quinazolinone and benzoxazine derivatives as progesterone receptor modulators |
US6462032B1 (en) | 1999-05-04 | 2002-10-08 | Wyeth | Cyclic regimens utilizing indoline derivatives |
US6407101B1 (en) | 1999-05-04 | 2002-06-18 | American Home Products Corporation | Cyanopyrroles |
US6358947B1 (en) | 1999-05-04 | 2002-03-19 | American Home Products Corporation | Tetracyclic progesterone receptor modulator compounds and methods |
US6391907B1 (en) | 1999-05-04 | 2002-05-21 | American Home Products Corporation | Indoline derivatives |
US6329416B1 (en) | 1999-05-04 | 2001-12-11 | American Home Products Corporation | Combination regimens using 3,3-substituted indoline derivatives |
US6444668B1 (en) | 1999-05-04 | 2002-09-03 | Wyeth | Combination regimens using progesterone receptor modulators |
UA73119C2 (en) | 2000-04-19 | 2005-06-15 | American Home Products Corpoir | Derivatives of cyclic thiocarbamates, pharmaceutical composition including noted derivatives of cyclic thiocarbamates and active ingredients of medicines as modulators of progesterone receptors |
WO2002070478A1 (fr) | 2001-03-06 | 2002-09-12 | Astrazeneca Ab | Dérivés indolone capable de dégrader des vaisseaux |
TW200508197A (en) | 2003-03-31 | 2005-03-01 | Ucb Sa | Indolone-acetamide derivatives, processes for preparing them and their uses |
ATE440826T1 (de) * | 2004-05-27 | 2009-09-15 | Ucb Pharma Sa | Benzoxazolonderivate, verfahren zu deren herstellung und deren anwendungen |
ATE482194T1 (de) * | 2004-07-22 | 2010-10-15 | Ucb Pharma Sa | Indolonderivate, verfahren zu deren herstellung und deren anwendungen |
GT200500185A (es) | 2004-08-09 | 2006-04-10 | Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos | |
WO2010090680A1 (fr) * | 2008-12-15 | 2010-08-12 | Wyeth Llc | Agonistes de cb2 de type oxindole substitué |
CN109662964A (zh) | 2010-02-09 | 2019-04-23 | 约翰斯.霍普金斯大学 | 用于改善认知功能的方法和组合物 |
CA2891122C (fr) | 2012-11-14 | 2021-07-20 | The Johns Hopkins University | Methodes et compositions pour le traitement de la schizophrenie |
AU2013357308B2 (en) | 2012-12-13 | 2017-08-31 | H. Lundbeck A/S | Compositions comprising vortioxetine and donepezil |
AU2014228512A1 (en) | 2013-03-15 | 2015-10-01 | Agenebio, Inc. | Methods and compositions for improving cognitive function |
US10806717B2 (en) | 2013-03-15 | 2020-10-20 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
CN103242332B (zh) * | 2013-05-13 | 2015-11-04 | 江西科技师范大学 | 1-n酰基取代吲哚酮衍生物 |
CN104530065A (zh) * | 2013-05-13 | 2015-04-22 | 江西科技师范大学 | 1-n酰基取代吲哚酮衍生物的应用 |
CA2986598C (fr) | 2015-05-22 | 2023-09-26 | Agenebio, Inc. | Compositions pharmaceutiques de levetiracetam a liberation prolongee |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH491106A (de) * | 1964-06-11 | 1970-05-31 | Ciba Geigy | Verfahren zur Herstellung von neuen Thiosemicarbazonen |
-
1993
- 1993-06-16 SE SE19939302080A patent/SE9302080D0/xx unknown
-
1994
- 1994-05-13 JP JP7501642A patent/JPH08511515A/ja active Pending
- 1994-05-13 EP EP94919032A patent/EP0703901A1/fr not_active Withdrawn
- 1994-05-13 CA CA002164119A patent/CA2164119A1/fr not_active Abandoned
- 1994-05-13 WO PCT/SE1994/000448 patent/WO1994029272A1/fr not_active Application Discontinuation
- 1994-05-13 AU AU70108/94A patent/AU7010894A/en not_active Abandoned
- 1994-05-18 IS IS4167A patent/IS4167A/is unknown
-
1995
- 1995-12-14 NO NO955074A patent/NO955074L/no unknown
- 1995-12-18 FI FI956074A patent/FI956074A0/fi not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JPH08511515A (ja) | 1996-12-03 |
NO955074L (no) | 1996-02-07 |
WO1994029272A1 (fr) | 1994-12-22 |
CA2164119A1 (fr) | 1994-12-22 |
EP0703901A1 (fr) | 1996-04-03 |
FI956074A (fi) | 1995-12-18 |
NO955074D0 (no) | 1995-12-14 |
AU7010894A (en) | 1995-01-03 |
IS4167A (is) | 1994-12-17 |
SE9302080D0 (sv) | 1993-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI956074A0 (fi) | Asetyylikolinesteraasin inhibiittoreina toimivia 1-asemasta substituoituja isatiini- ja oksindolijohdannaisia | |
ATE225784T1 (de) | Indan- oder dihydroindolderivate | |
NO301879B1 (no) | Indol-derivater | |
FI962315A0 (fi) | Entsyymi-inhibiittorit | |
NO992725L (no) | 6-Fenylpyridyl-2-amin-derivater anvendelige som NOS-inhibitorer | |
FI944969A (fi) | Indolijohdannaisia | |
DE69634416D1 (de) | Chinolin-derivate | |
FI940393A0 (fi) | Kinatsoliinijohdannaiset asetyylikoliiniesteraasi-inhibiittoreina | |
EP0707581A1 (fr) | Derives indoliniques utilises comme antagonistes de 5ht 2c? | |
DK0892796T3 (da) | Isatinderivater som acetylcholinesteraseinhibitorer og analgetika | |
NO961475L (no) | Indol-derivater | |
PL337645A1 (en) | Novel amidine derivatives and their application as thrombosin inhibitors | |
PT934280E (pt) | Derivados 2-cianoiminoimidazolo inibidores da pde iv | |
AU1766997A (en) | Beta-thiopropionyl-aminoacid derivatives and their use as beta-lactamase inhibitors | |
FI961977A (fi) | N-substituoidut atsabisykloalkaanijohdannaiset, niiden valmistus ja käyttö | |
GB9420287D0 (en) | 3-substituted heterocyclic indoles as inhibitors of HIV reverse transcriptase | |
LV11328A (lv) | 1-(2-fluorciklopropil)-hinolona un naftiridonkarbonskabes atvasinajumi | |
DE69720957T2 (de) | Ace-hemmer | |
DE69431454D1 (de) | Amylase Inhibitoren | |
DE69418656D1 (de) | 2-acyloxycephemderivate als elastaseinhibitoren | |
SI0892796T1 (en) | Isatin derivatives as acetylcholinesterase inhibitors and analgesics | |
DE59706183D1 (de) | Tetrahydropyrimidin-derivate | |
NO951241D0 (no) | Forbedret indolbiosyntese | |
ZA941092B (en) | Indolin-2-one derivatives | |
NO934473D0 (no) | N-substituerte azabicykloheptanderivater |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application lapsed |